Recent Updates
Recently added Catalysts
HNGE Positive Sentiment Score: 85/100

Hinge Health launches comprehensive Migraine Care Program

Key Takeaway: Hinge Health has launched a new Migraine Care Program aimed at providing drug-free pain relief and personalized management for migraine sufferers. The program utilizes the FDA-cleared Enso device, which offers rapid pain relief, alongside AI-powered insights for trigger management. With a focus on proactive prevention through exercise therapy, the program is set to roll out in May 2026 and has already gained significant employer interest.

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of a comprehensive Migraine Care Program
  • FDA clearance of the Enso device for rapid pain relief
  • Personalized insights for trigger management
  • Adoption by over 125 clients covering more than two million people

Full Press Release Details

Key Points:

  • Cleared by the FDA for migraine, Hinge Health’s Enso® delivers on-demand pain relief
  • Already 125+ clients covering more than two million people have adopted the Migraine Care Program
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for people living with migraine, MSK pain, or both.
Migraine affects one in six Americans, with double the prevalence for women versus men¹. Approximately 75% of those who suffer from migraine pain also have MSK pain² and the personal and financial burden is significant. People with migraine drive more than $16,000 in annual medical and pharmaceutical spend – over twice as much as those without migraine³. Nationally, migraine costs U.S. businesses an estimated $78 billion each year⁴, and drives absenteeism and reduced productivity.
“Migraine is one of the most disabling and widespread neurologic conditions, yet existing treatment options are insufficient,” said Dr. Jeffrey Krauss, MD, Chief Medical Officer of Hinge Health. “The FDA recently cleared our proprietary Enso device for the treatment of migraine, enabling us to deliver a first-of-its-kind care solution that combines groundbreaking technology with a full care team.”
The Hinge Health migraine care program will offer:

Key Points:

  • **Rapid, drug-free pain relief:**Hinge Health's FDA-cleared Enso, a specialized wearable device designed for pain relief, now reduces migraine pain in minutes.
  • Personalized trigger tracking & insights: AI-powered insights help members identify and manage migraine triggers across environmental, lifestyle, and dietary factors.
  • Proactive prevention: Exercise therapy and lifestyle guidance led by expert care teams reduce the frequency and severity of migraine attacks, stopping the pain before it starts.
To date, more than 125 clients covering more than two million people have adopted the Hinge Health Migraine Care Program, signaling that employers are ready to act on one of the leading causes of disability for people under 50 years of age⁵.
“We’re excited to introduce this Migraine Care Program especially because our employees consistently share positive experiences with Hinge Health’s offerings,” says Rachel Harrell, Manager of Benefits Strategy for Sodexo, a food and facilities management company. “We’re committed to expanding benefits that truly make a difference."
The Migraine Care Program will roll out in May 2026. Learn more here.

About Hinge Health

Hinge Health is focused on scaling and automating the delivery of health care. Leveraging an AI-powered care model, wearable devices, and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that improves member outcomes and experiences, while reducing costs for clients. The company is headquartered in San Francisco, California.
References

Frequently Asked Questions

What does the Hinge Health Migraine Care Program offer?

The program provides rapid drug-free pain relief, personalized trigger management, and expert-led prevention.

When will the Migraine Care Program be available?

The program is set to roll out in May 2026.

How does the Enso device work?

The Enso device is FDA-cleared and designed to reduce migraine pain within minutes.

Who can benefit from the Migraine Care Program?

The program is aimed at individuals suffering from migraines and musculoskeletal pain.

How many clients have adopted the program?

Over 125 clients covering more than two million people have adopted the program.

Last updated: Apr 29, 2026